Clinical Trial Update: Study to Assess Long-Term Outcomes of Trientine in Wilson Disease Patients Withdrawn From Therapy With d-Penicillamine [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the long-term outcomes of trientine in Wilson disease patients who were withdrawn from d-penicillamine therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wilson Disease

Drugs mentioned

• D-Penicillamine (D-penicillamine)
• Trientine (trientine)

Snippet

Sponsor: Univar BV | Conditions: Wilson Disease | Phase 4 | Status: UNKNOWN